Theragyn: Halted Phase III enrollment

By WIR Staff | May 30, 2000 | 7:00 AM GMT

Antisoma plc (LSE:ASM; EASD:ASOM), London, U.K.
Product: Theragyn
Business: Cancer
Therapeutic category: Antibody,